Cleviprex Recall Issued Due to Stainless Steel Particles

The FDA announced a recall of Cleviprex on Thursday, indicating that certain lots of the hypertension drug may be contaminated with stainless steel particles that could reduce blood flow and lead to potentially lead to serious injury.

Cleviprex (clevidipine butyrate) is an intravenously-delivered drug used to reduce blood pressure, manufactured by The Medicines Company. The Cleviprex recall was issued after visible particles were found in vials during an annual inspection.

“If the particles were to aggregate, or if larger particles were present, then they could theoretically reduce blood flow in capillaries, cause mechanical damage to some tissues, or initiate acute or chronic inflammatory reactions,” warned the FDA in a statement posted December 17, 2009. “Reduced blood supply to tissues may lead to ischemia or organ insufficiency in the brain, kidney, liver, heart or lungs.”

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

There have been no injuries reported in association with the contaminated Cleviprex vials.

The recall affects the following 11 lots of Cleviprex injectable emulsion: 61-978-DW, 61-979-DW, and 61-980-DW, Exp. 01/2010; 68-404-DJ, 68-405-DJ, and 68-406-DJ, Exp. 08/2010; 69-830-DJ, 63-385-DJ, 63-386-DJ, and 63-266-DJ, Exp 03/2011; and 64-453-DJ, Exp. 04/2011. The recall is limited to these lots.

Any health care professionals with recalled lots of Cleviprex in their inventory should return the product to the pharmaceutical distributor or wholesaler where it was purchased. The Medicines Company is currently shipping additional batches from unaffected lots to wholesalers.

Any adverse reactions from the use of Cleviprex should be reported to the FDA’s MedWatch Program at www.fda.gov/medwatch.

Tags: Cleviprex

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination
Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination (Posted today)

A group of 19 plaintiffs' lawyers have been appointed to serve in various leadership position during the consolidated pretrial proceedings for all baby food injury lawsuits, taking actions that benefit all families pursuing claims for children diagnosed with autism, ADHD or other developmental problems from toxic heavy metals found in many popular products sold in recent years.

Court Allows Suboxone Tooth Decay Lawsuits To Be Filed in Bundled Complaint by June 14, 2024
Court Allows Suboxone Tooth Decay Lawsuits To Be Filed in Bundled Complaint by June 14, 2024 (Posted 3 days ago)

A federal judge is allowing plaintiffs to file large numbers of Suboxone tooth decay lawsuits in one bundled complaint, to meet a potential two-year statute of limitations deadline, with the ability to flesh those claims out in more detail at a later date.